Vadim Divilov

1.3k total citations
16 papers, 1.1k citations indexed

About

Vadim Divilov is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Vadim Divilov has authored 16 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 6 papers in Oncology and 6 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Vadim Divilov's work include Radiopharmaceutical Chemistry and Applications (6 papers), HER2/EGFR in Cancer Research (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Vadim Divilov is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (6 papers), HER2/EGFR in Cancer Research (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Vadim Divilov collaborates with scholars based in United States, Denmark and Poland. Vadim Divilov's co-authors include Jason S. Lewis, Jason P. Holland, Brian M. Zeglis, Neil H. Bander, Steven M. Larson, Peter Smith‐Jones, Sean Carlin, Carola Heneweer, Gabriela Chiosis and Scott A. Hilderbrand and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Vadim Divilov

13 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vadim Divilov United States 9 597 397 276 275 236 16 1.1k
Nerissa T. Viola United States 19 563 0.9× 446 1.1× 310 1.1× 191 0.7× 116 0.5× 39 1.2k
Lihui Wei United States 16 757 1.3× 365 0.9× 304 1.1× 157 0.6× 155 0.7× 37 1.2k
F.J. Femia United States 20 860 1.4× 511 1.3× 246 0.9× 425 1.5× 282 1.2× 35 1.4k
Alexandra D. Varvarigou Greece 19 733 1.2× 371 0.9× 214 0.8× 216 0.8× 97 0.4× 70 1.1k
Christopher D'Souza United States 12 752 1.3× 441 1.1× 286 1.0× 223 0.8× 221 0.9× 23 1.2k
Darpan N. Pandya United States 20 741 1.2× 343 0.9× 144 0.5× 266 1.0× 79 0.3× 42 1.0k
Frederik Cleeren Belgium 20 721 1.2× 474 1.2× 204 0.7× 147 0.5× 133 0.6× 47 1.2k
Alan Cuthbertson Norway 22 925 1.5× 377 0.9× 380 1.4× 368 1.3× 184 0.8× 52 1.4k
Paul Jurek United States 14 767 1.3× 480 1.2× 205 0.7× 245 0.9× 154 0.7× 25 1.2k
Helen Merkens Canada 20 589 1.0× 387 1.0× 391 1.4× 325 1.2× 203 0.9× 66 1.5k

Countries citing papers authored by Vadim Divilov

Since Specialization
Citations

This map shows the geographic impact of Vadim Divilov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vadim Divilov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vadim Divilov more than expected).

Fields of papers citing papers by Vadim Divilov

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vadim Divilov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vadim Divilov. The network helps show where Vadim Divilov may publish in the future.

Co-authorship network of co-authors of Vadim Divilov

This figure shows the co-authorship network connecting the top 25 collaborators of Vadim Divilov. A scholar is included among the top collaborators of Vadim Divilov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vadim Divilov. Vadim Divilov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
2.
Divilov, Vadim, et al.. (2023). A 21-Year-Old Hispanic Woman Presenting With Cutaneous and Pulmonary Nodules. CHEST Journal. 163(4). e167–e171.
4.
Divilov, Vadim, Varun Kesar, & Ramona Rajapakse. (2017). Granulomatous Dermatitis and Lichenoid Dermatosis After Exposure to Pantoprazole and Lansoprazole: A Case Report. The American Journal of Gastroenterology. 112. S1408–S1408.
5.
Zeglis, Brian M., Nicholas Ramos, Vadim Divilov, et al.. (2014). Synthesis and evaluation of 18F-labeled ATP competitive inhibitors of topoisomerase II as probes for imaging topoisomerase II expression. European Journal of Medicinal Chemistry. 86. 769–781. 10 indexed citations
6.
Viola, Nerissa T., Sean Carlin, Ellen Ackerstaff, et al.. (2014). Understanding the pharmacological properties of a metabolic PET tracer in prostate cancer. Proceedings of the National Academy of Sciences. 111(20). 7254–7259. 37 indexed citations
7.
Andersen, Kim Francis, Vadim Divilov, Jacek Koziorowski, Nagavarakishore Pillarsetty, & Jason S. Lewis. (2013). Antilipolytic drug boosts glucose metabolism in prostate cancer. Nuclear Medicine and Biology. 40(4). 524–528. 5 indexed citations
8.
Janjigian, Yelena Y., Nerissa T. Viola, Jason P. Holland, et al.. (2013). Monitoring Afatinib Treatment in HER2-Positive Gastric Cancer with 18F-FDG and 89Zr-Trastuzumab PET. Journal of Nuclear Medicine. 54(6). 936–943. 79 indexed citations
9.
Andersen, Kim Francis, et al.. (2013). Influence of free fatty acids on glucose uptake in prostate cancer cells. Nuclear Medicine and Biology. 41(3). 254–258. 7 indexed citations
10.
Heneweer, Carola, Jason P. Holland, Vadim Divilov, Sean Carlin, & Jason S. Lewis. (2011). Magnitude of Enhanced Permeability and Retention Effect in Tumors with Different Phenotypes: 89Zr-Albumin as a Model System. Journal of Nuclear Medicine. 52(4). 625–633. 137 indexed citations
11.
Zeglis, Brian M., Nagavarakishore Pillarsetty, Vadim Divilov, Ronald Blasberg, & Jason S. Lewis. (2011). The synthesis and evaluation of N1-(4-(2-[18F]-fluoroethyl)phenyl)-N8-hydroxyoctanediamide ([18F]-FESAHA), A PET radiotracer designed for the delineation of histone deacetylase expression in cancer. Nuclear Medicine and Biology. 38(5). 683–696. 16 indexed citations
12.
Zeglis, Brian M., Priya Mohindra, Vadim Divilov, et al.. (2011). Modular Strategy for the Construction of Radiometalated Antibodies for Positron Emission Tomography Based on Inverse Electron Demand Diels–Alder Click Chemistry. Bioconjugate Chemistry. 22(10). 2048–2059. 135 indexed citations
13.
Janjigian, Yelena Y., et al.. (2011). Positron emission tomography (PET) with 89Zr-labeled trastuzumab (89Zr-trastuzumab): Monitoring HER2 expression in HER2-positive gastric cancer in vivo.. Journal of Clinical Oncology. 29(4_suppl). 35–35. 1 indexed citations
14.
Zeglis, Brian M., Vadim Divilov, & Jason S. Lewis. (2011). Role of Metalation in the Topoisomerase IIα Inhibition and Antiproliferation Activity of a Series of α-Heterocyclic-N4-Substituted Thiosemicarbazones and Their Cu(II) Complexes. Journal of Medicinal Chemistry. 54(7). 2391–2398. 180 indexed citations
15.
Holland, Jason P., Vadim Divilov, Neil H. Bander, et al.. (2010). 89Zr-DFO-J591 for ImmunoPET of Prostate-Specific Membrane Antigen Expression In Vivo. Journal of Nuclear Medicine. 51(8). 1293–1300. 338 indexed citations
16.
Holland, Jason P., Eloisi Caldas-Lopes, Vadim Divilov, et al.. (2010). Measuring the Pharmacodynamic Effects of a Novel Hsp90 Inhibitor on HER2/neu Expression in Mice Using 89Zr-DFO-Trastuzumab. PLoS ONE. 5(1). e8859–e8859. 114 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026